This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Harwood Feffer LLP (
www.hfesq.com) is investigating potential claims against the board of directors of Animal Health International, Inc. ("Animal Health" or the "Company") (NASDAQ: AHII - News) concerning the Company’s agreement to merge with Lextron, Inc. (“Lextron”) in a transaction valued at approximately $251 million.
On or about March 14, 2011, Animal Health and Lextron announced that they had entered into a definitive merger agreement with support from investment funds from Leonard Green & Partners, LP, pursuant to which Lextron would acquire all the outstanding shares of common stock of Animal Health for $4.26 per share plus the repayment of debt. Investment funds affiliated with Charlesbank Capital Partners, and Jim Robison, Animal Health’s Chairman, President, and CEO, who together own approximately 33% of Animal Health’s outstanding common stock, have agreed to vote in favor of the transaction. Our investigation concerns whether the board of directors is undertaking a fair process to obtain fair consideration for all shareholders of Animal Health. The median target price, according to Yahoo Finance, is $4.50 per share.